approval
saveOXCARBAZEPINE — FDA approval
community read0 votes
Sponsor: EPIC PHARMA LLC. Form: TABLET. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalTRILEPTAL (OXCARBAZEPINE) — FDA approvalSep 23, 2025 · 376d ago
- approvalTRILEPTAL (OXCARBAZEPINE) — FDA approvalSep 23, 2025 · 376d ago
- approvalTRILEPTAL (OXCARBAZEPINE) — FDA approvalSep 4, 2024 · 760d ago
- approvalTRILEPTAL (OXCARBAZEPINE) — FDA approvalSep 4, 2024 · 760d ago
- approvalTRILEPTAL (OXCARBAZEPINE) — FDA approvalJan 4, 2019 · 2830d ago
- approvalTRILEPTAL (OXCARBAZEPINE) — FDA approvalJan 4, 2019 · 2830d ago
- approvalTRILEPTAL (OXCARBAZEPINE) — FDA approvalMar 22, 2018 · 3118d ago
- approvalTRILEPTAL (OXCARBAZEPINE) — FDA approvalMar 22, 2018 · 3118d ago
same company · ±60 days · 6
- approvalFLUOXETINE HYDROCHLORIDE: OLANZAPINE AND FLUOXETINE HYDROCHLORIDE (FLUOXETINE HYDROCHLORIDE) — FDA approvalFeb 6, 2026
- approvalXalatan: LATANOPROST — FDA approvalJan 30, 2026
- approvalOLANZAPINE AND FLUOXETINE HYDROCHLORIDE (FLUOXETINE HYDROCHLORIDE) — FDA approvalJan 30, 2026
- approvalOLANZAPINE AND FLUOXETINE HYDROCHLORIDE (FLUOXETINE HYDROCHLORIDE) — FDA approvalJan 30, 2026
- approvalXalatan: LATANOPROST — FDA approvalJan 30, 2026
- approvalXalatan: LATANOPROST — FDA approvalJan 30, 2026
comments(0)
5-min edit window · permanent after that